LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

Search

Codexis Inc

Chiusa

SettoreSettore sanitario

2.45 0.41

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

2.43

Massimo

2.47

Metriche Chiave

By Trading Economics

Entrata

10M

-10M

Vendite

8.6M

21M

EPS

-0.13

Margine di Profitto

-48.35

Dipendenti

188

EBITDA

3.8M

-9.9M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+171.14% upside

Dividendi

By Dow Jones

Utili prossimi

14 mag 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-18M

209M

Apertura precedente

2.04

Chiusura precedente

2.45

Notizie sul Sentiment di mercato

By Acuity

46%

54%

164 / 382 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bullish Evidence

Codexis Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

11 mag 2025, 23:48 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Dyno Nobel Returns to 1st Half Profit; Strikes Fertilizers Deals -- Update

11 mag 2025, 23:46 UTC

Discorsi di Mercato

Nikkei May Rise on Hopes for U.S.-China Trade Talks -- Market Talk

11 mag 2025, 23:45 UTC

Discorsi di Mercato

Oil Rises Amid Improved Market Mood -- Market Talk

11 mag 2025, 23:38 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Aristocrat Has Significant Firepower for M&A -- Market Talk

11 mag 2025, 23:36 UTC

Discorsi di Mercato

Global Markets Uncertain About US-China Trade News -- Market Talk

11 mag 2025, 23:35 UTC

Discorsi di Mercato

Gold Falls, Dragged by Weakening Safe-Haven Demand, Possible Profit-Taking -- Market Talk

11 mag 2025, 23:33 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Dyno Nobel Returns to 1H Profit; Strikes Fertilizers Deals -- Update

11 mag 2025, 23:32 UTC

Notizie principali

Proposal Cutting Medicaid Aims for GOP Middle Ground -- WSJ

11 mag 2025, 22:44 UTC

Discorsi di Mercato

Centaurus Metals's Jaguar Project Faces Funding Hurdles -- Market Talk

11 mag 2025, 22:33 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Domain Takeover Could Create Near-Term Overhang on REA Stock -- Market Talk

11 mag 2025, 20:19 UTC

Notizie principali

Bessent Says U.S.-China Trade Talks Were 'Productive,' Without Offering Specifics -- WSJ

11 mag 2025, 16:00 UTC

Notizie principali

Trump's Budget Hawk Takes Over the DOGE Agenda. First Up: the Military -- WSJ

11 mag 2025, 11:00 UTC

Notizie principali

This Obscure New York Court Is Set to Decide Fate of Trump's Tariffs -- WSJ

11 mag 2025, 08:00 UTC

Notizie principali

China's Property Market Is a Tale of Big Cities. Everywhere Else Is Struggling. -- Barrons.com

11 mag 2025, 01:00 UTC

Notizie principali

The Spring Home Sales Season Is Shaping Up to Be a Dud -- WSJ

11 mag 2025, 01:00 UTC

Notizie principali

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia on Cease-Fire -- WSJ

10 mag 2025, 21:54 UTC

Notizie principali

GOP Tax Bill Seeks to Put Cash in Taxpayers' Pockets in Early 2026 -- Update

10 mag 2025, 17:12 UTC

Notizie principali

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia to Cease Fire -- WSJ

10 mag 2025, 15:41 UTC

Notizie principali

Fed Officials Signal Pause on Adjusting Interest Rates as Trade Risks Mount -- Barrons.com

10 mag 2025, 12:00 UTC

Notizie principali

Why a Sorority Is Taking on Trump's Budget Cuts -- WSJ

10 mag 2025, 09:30 UTC

Notizie principali

The Giants of Silicon Valley Are Having a Midlife Crisis Over AI -- WSJ

10 mag 2025, 08:20 UTC

Discorsi di Mercato

Tech, Media & Telecom Roundup: Market Talk

10 mag 2025, 03:52 UTC

Notizie principali

China Struggles With Persistent Disinflationary Pressures as Tariffs Bite -- WSJ

9 mag 2025, 23:51 UTC

Acquisizioni, Fusioni, Takeovers

Oil at $50? The High Cost of Cheap Crude. -- Barrons.com

9 mag 2025, 22:06 UTC

Discorsi di Mercato

Arm Holdings Remains a Strong Growth Story -- Market Talk

9 mag 2025, 21:37 UTC

Notizie principali

U.S. Sets August Deadline for Debt Ceiling -- WSJ

9 mag 2025, 21:10 UTC

Notizie principali

The Score: Disney, Berkshire Hathaway, Ford and More Stocks That Defined the Week -- WSJ

9 mag 2025, 20:50 UTC

Discorsi di Mercato

Tech, Media & Telecom Roundup: Market Talk

9 mag 2025, 20:50 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

9 mag 2025, 20:42 UTC

Notizie principali

Stocks Get a Break From Trade Chaos -- WSJ

Confronto tra pari

Modifica del prezzo

Codexis Inc Previsione

Obiettivo di Prezzo

By TipRanks

171.14% in crescita

Previsioni per 12 mesi

Media 6.67 USD  171.14%

Alto 11 USD

Basso 4 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Codexis Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

4 ratings

3

Acquista

1

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

2.25 / 2.53Supporto e resistenza

A breve termine

Bullish Evidence

A termine intermedio

Strong Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

164 / 382 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.